Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Patients also get access to behavior-change lessons and a habit tracker to record medication, weight, sleep, movement, and nutrition
Where Ozempic (semaglutide) is a pure GLP-1 receptor agonist, Retatrutide is a triple agonist working on: GLP-1 improves insulin sensitivity, reduces appetite, slows stomach emptying GIP (Glucose-dependent insulinotropic peptide) enhances insulin secretion, may preserve beta cells, and appears to help prevent the dreaded weight plateau seen with GLP-1 alone Glucagon receptor promotes fat metabolism and increases energy expenditure This means that not only does Retatrutide regulate blood sugar and suppress appetite like Ozempic it also burns more fat and preserves more muscle while you lose weight
clinical rationale for the specific compound and formulation
Peak areas of the identified metabolites were obtained using vendors integration software: ChromaTOF (LECO) and MultiQuant (Sciex)
Brandon Richland, MD Semaglutide is a glucagon-like peptide 1 or GLP 1 analog injection used to treat type 2 diabetes and obesity
US$ 28.40
US$ 23.65
US$ 20.76
US$ 26.65
